BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30261824)

  • 1. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
    Yadav D; Nath Mishra B; Khan F
    J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity.
    Alam S; Khan F
    J Biomol Struct Dyn; 2018 Jul; 36(9):2373-2390. PubMed ID: 28705120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7.
    Alam S; Khan F
    Sci Rep; 2017 Jul; 7(1):6019. PubMed ID: 28729623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationship and molecular docking studies on human proteasome inhibitors for anticancer activity targeting NF-κB signaling pathway.
    Yadav D; Mishra BN; Khan F
    J Biomol Struct Dyn; 2020 Aug; 38(12):3621-3632. PubMed ID: 31514715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies.
    Alam S; Nasreen S; Ahmad A; Darokar MP; Khan F
    Curr Top Med Chem; 2021; 21(8):686-695. PubMed ID: 33280598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
    Jarapula R; Badavath VN; Rekulapally S; Manda S
    Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR guided semi-synthesis and in-vitro validation of anticancer activity in ursolic acid derivatives.
    Kalani K; Yadav DK; Singh A; Khan F; Godbole MM; Srivastava SK
    Curr Top Med Chem; 2014; 14(8):1005-13. PubMed ID: 24660684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-κB.
    Jiang W; Huang RZ; Zhang J; Guo T; Zhang MT; Huang XC; Zhang B; Liao ZX; Sun J; Wang HS
    Bioorg Chem; 2018 Sep; 79():265-276. PubMed ID: 29778798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity.
    Alam S; Khan F
    Sci Rep; 2018 Apr; 8(1):5524. PubMed ID: 29615704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
    Alam S; Khan F
    Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
    Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
    Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.